Assessment
Questionnaire
Have a symptom?
See what questions
a doctor would ask.
See what questions
a doctor would ask.
It has already been acknowledged that hormone replacement therapy increases the risk of breast and endometrial cancer, coronary heart disease and stroke. New research has examined the link with ovarian cancer. The results indicated that cumulative oral intake of estrogen was a significant factor in increasing the risk of ovarian cancer. The progesterone component of hormone therapy had no effect on incidence of ovarian cancer. Thus, it is important that estrogen use should be minimized or replaced with progestogen only if possible.
Source: summary of medical news story as reported by Reuters Health - Archives of Internal Medicine
About: Oral estrogen directly increases the risk of ovarian cancer
Date: 25 November 2004
Source: Reuters Health - Archives of Internal Medicine
URL:
http:/ This summary article refers to the following medical categories:
Tools & Services:
Medical Articles:
Related Medical Topics
More News Topics
» Next page: Oral health and overall wellbeing
Medical Tools & Articles:
Forums & Message Boards
Search Specialists by State and City
By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.
Copyright © 2011 Health Grades Inc. All rights reserved. Last Update: 6 May, 2013 (23:56)
